HK2
Basic information
Region (hg38): 2:74834127-74893359
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 20 | ||||
missense | 55 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 55 | 17 | 11 |
Variants in HK2
This is a list of pathogenic ClinVar variants found in the HK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-74834625-C-G | not specified | Uncertain significance (Mar 17, 2023) | ||
2-74854341-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
2-74854353-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
2-74854359-C-T | not specified | Uncertain significance (Jun 23, 2023) | ||
2-74854425-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
2-74867690-G-T | not specified | Uncertain significance (May 29, 2024) | ||
2-74867737-C-A | not specified | Uncertain significance (Aug 17, 2022) | ||
2-74867748-C-T | HK2-related disorder | Likely benign (Apr 09, 2019) | ||
2-74867791-C-A | Likely benign (Jun 27, 2018) | |||
2-74872350-A-T | HK2-related disorder | Benign (Oct 28, 2019) | ||
2-74872389-G-A | HK2-related disorder | Likely benign (Aug 20, 2019) | ||
2-74873281-C-T | HK2-related disorder | Likely benign (Apr 25, 2019) | ||
2-74873334-T-C | not specified | Uncertain significance (Aug 22, 2022) | ||
2-74873342-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
2-74873346-T-A | not specified | Uncertain significance (Jul 19, 2023) | ||
2-74873348-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
2-74873381-G-A | HK2-related disorder | Benign (Apr 25, 2019) | ||
2-74873855-C-T | HK2-related disorder | Likely benign (Feb 27, 2019) | ||
2-74873929-T-C | not specified | Uncertain significance (Aug 23, 2021) | ||
2-74874327-T-C | HK2-related disorder | Benign (Oct 23, 2019) | ||
2-74874328-G-A | not specified | Uncertain significance (Apr 11, 2023) | ||
2-74874357-G-C | not specified | Uncertain significance (May 04, 2023) | ||
2-74874364-T-C | not specified | Uncertain significance (Aug 30, 2022) | ||
2-74874436-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
2-74874437-C-T | not specified | Uncertain significance (Jun 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HK2 | protein_coding | protein_coding | ENST00000290573 | 18 | 59379 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00459 | 0.995 | 125716 | 0 | 32 | 125748 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 477 | 553 | 0.862 | 0.0000382 | 6040 |
Missense in Polyphen | 151 | 221.87 | 0.68059 | 2578 | ||
Synonymous | -1.32 | 243 | 218 | 1.11 | 0.0000155 | 1801 |
Loss of Function | 4.11 | 12 | 40.1 | 0.299 | 0.00000234 | 469 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000427 | 0.000423 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000933 | 0.0000924 |
European (Non-Finnish) | 0.0000971 | 0.0000967 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);Central carbon metabolism in cancer - Homo sapiens (human);Type II diabetes mellitus - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);Starch and sucrose metabolism - Homo sapiens (human);Carbohydrate digestion and absorption - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Neomycin, kanamycin and gentamicin biosynthesis - Homo sapiens (human);Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Warburg Effect;Glycolysis;Glycogenosis, Type VII. Tarui disease;Gluconeogenesis;Starch and Sucrose Metabolism;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Fanconi-bickel syndrome;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;Pathways in clear cell renal cell carcinoma;Glycolysis and Gluconeogenesis;Aminosugars metabolism;Metabolism of carbohydrates;Fructose Mannose metabolism;Glycolysis Gluconeogenesis;Metabolism;Glycolysis;GDP-glucose biosynthesis II;glycolysis;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Glucose metabolism;HIF-1-alpha transcription factor network;Galactose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.458
Intolerance Scores
- loftool
- 0.0828
- rvis_EVS
- -0.95
- rvis_percentile_EVS
- 9.38
Haploinsufficiency Scores
- pHI
- 0.544
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hk2
- Phenotype
- cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; neoplasm;
Gene ontology
- Biological process
- response to hypoxia;cellular glucose homeostasis;response to ischemia;glycolytic process;lactation;apoptotic mitochondrial changes;negative regulation of mitochondrial membrane permeability;positive regulation of angiogenesis;regulation of glucose import;carbohydrate phosphorylation;glucose 6-phosphate metabolic process;canonical glycolysis;establishment of protein localization to mitochondrion;maintenance of protein location in mitochondrion;positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization;cellular response to leukemia inhibitory factor;negative regulation of reactive oxygen species metabolic process
- Cellular component
- mitochondrial outer membrane;cytosol;plasma membrane;membrane;sarcoplasmic reticulum
- Molecular function
- glucokinase activity;hexokinase activity;protein binding;ATP binding;glucose binding;fructokinase activity;mannokinase activity